Back to UBS Group AG UBS Group AG

BRNSBRNS
17 quarters

Position history for UBS Group AGUBS Group AG's holdings in BARINTHUS BIOTHERAPEUTICS PL

UBS Group AG holds 1,008 shares of BRNS (BARINTHUS BIOTHERAPEUTICS PL), worth $665 as of 2026-Q2. This is a new position.

Current Value

$665

Current Shares

1,008

Total Value Change

-$5,335

Total Shares Change

+435

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
1,008
-
$6650.0%$0.66
17
2026-Q1
Exited
0
-100.0%
$00.0%$0.60
0
2025-Q4
Increased
3,152
+241x
$2,2060.0%$0.68
13
2025-Q3
New
13
-
$160.0%$1.48
17
2024-Q4
Exited
0
-100.0%
$00.0%$1.10
0
2024-Q3
Decreased
1,432
-98.3%
$1,7040.0%$1.18
0
2024-Q2
Increased
86,653
+5501.4%
$121,3140.0%$1.40
24
2024-Q1
Unchanged
1,547
0.0%
$3,6820.0%$2.38
0
2023-Q4
Increased
1,547
+1638.2%
$5,7080.0%$3.69
17
2023-Q3
Decreased
89
-91.0%
$2750.0%$3.09
0
2023-Q2
New
993
-
$2,0460.0%$2.16
17
2023-Q1
Exited
0
-100.0%
$00.0%$2.30
0
2022-Q4
Decreased
3,751
-27.7%
$8,8150.0%$2.35
0
2022-Q3
Increased
5,188
+1022.9%
$17,0000.0%$3.11
20
2022-Q2
Decreased
462
-76.4%
$2,0000.0%$5.11
0
2022-Q1
Increased
1,956
+241.4%
$10,0000.0%$4.79
19
2021-Q4
New
573
-
$6,0000.0%$10.65
24

Other major holders of BRNS: M&G Plc, TUDOR INVESTMENT CORP ET AL, Alphabet Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used